Loading...
•
Dec 31, 2021
Medifast Q4 2021 Earnings Report
Medifast reported a revenue increase of 42.6% to $377.8 million and EPS of $2.91 for Q4 2021.
Key Takeaways
Medifast reported strong Q4 2021 results, with a 42.6% increase in revenue to $377.8 million compared to the prior-year period. The company's EPS increased by 23.3% to $2.91. The growth was driven by an increase in active earning OPTAVIA Coaches and their productivity.
Revenue increased 42.6% to $377.8 million.
Active earning OPTAVIA Coaches increased 35.3% to 59,800.
Revenue per active earning OPTAVIA Coach increased 6.6% to $6,321.
Net income increased 21.5% to $34.0 million.
Forward Guidance
The Company expects full-year 2022 revenue to be in the range of $1.72 billion to $1.79 billion and full-year 2022 diluted EPS to be in the range of $14.50 to $16.00. The full-year 2022 earnings guidance assumes a 24.25% to 25.25% effective tax rate.
Positive Outlook
- Full-year 2022 revenue to be in the range of $1.72 billion to $1.79 billion
- Full-year 2022 diluted EPS to be in the range of $14.50 to $16.00
- Earnings guidance assumes a 24.25% to 25.25% effective tax rate.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...